Rare
lephants
Screener
Toggle theme
Biomerica, Inc.
BMRA
·
Healthcare, Drug Manufacturers - General, United States
Analysis
Financial Statements
Profitability
Balance Sheet
Cash Flow
Price Ratios
Share-Based Metrics
Valuation
Cash Flow History
Net Cash Flow Breakdown
Net Cash Flow
Cash Flow
›
Net Cash Flow Breakdown
Net Cash Flow Breakdown
Chart
Table
FY2013
FY2012
FY2011
Total Cash from Operations:
$366.7K
Line Item
Value
% of Total
Capital Expenditures
$141.1K
38.5%
Other Investing
$225.6K
61.5%
Net Cash Flow
$0
0.0%
Download CSV
